CREATING HEALTHCARE BY COMBINING
SCIENCE & DIGITAL TECHNOLOGY

OUR FOCUS

CureOmics is a life science company dedicated to improve therapeutic and preventive options for the treatment of unmet healthcare needs. We build solutions to improve health by use of life sciences, digital technologies and data science. CureOmics' research & development is tailored to create digital innovations as well as novel drug and food-supplement products. Separated from own R&D, the company offers management consulting services to strategic partners.

01 / RESEARCH

CureOmics pursues R&D for digital innovations, drug products and food-supplements.

 

CureOmics' digital innovation addresses major challenges of today's drug product development process and improves patients experience in disease treatment. We cross borders of traditional healthcare solutions and integrate cutting-edge information technologies as central tool to create insight, improve cure and well being.

Our digital technology is designed to improve safety and efficacy profiles of drug treatments during product development while simultaneous creating  value adding intellectual property. We believe in high quality data science and use stringent stratified healthcare data as foundation for intelligent technologies.

With solution tailored research, we develop new therapeutic and healthcare options being translated into a pipeline of drug products and novel food-supplements.

02 / PIPELINE

CureOmics' development of drug products and food-supplements employs cutting edge life-science for translating molecular solutions into a pipeline of novel health care options.

 

We use a broad spectrum of data to isolate opportunities that positively impact the treatment or prevention of diseases.

 

CureOmics also uses evidence based scientific data from clinical and non-clinical research, to build healthcare opportunities by use of re-purposing existing drug substances for new clinical indications.

 

For efficient and scalable operations, CureOmics cooperates with established third party partners for formulation development and manufacturing.

03 / CONSULTING

Separated from our research and development operations, we aim to support our partners and clients through tailored approaches to create business success. CureOmics' management consulting services for pharmaceutical, nutrition and medicinal product sectors include:

  • Licensing deal & partnering

  • Digital strategy

  • Biologics product development

  • Small molecule therapy development

  • Marketing strategy

  • GxP and regulatory affairs

CMO & CRO services

CureOmics has entered strategic CRO and CMO partnerships in Europe, India and China offering with these partners the development of innovative biologics, biosimilars and small molecule therapies.

 

OUR SCIENCE

Digital Technology

 

OUR SCIENCE

In organs, single cells are highly specialized in its subcellular and molecular organization enabling the tissue to manage efficiently complex tasks and outstanding performances. CureOmics adopts the principles of natural integrated intelligence and builds separated entrepreneurial nuclei being independent, highly specialized, efficient for research and development, and organized within a greater functional structure. Our nuclei of research and product development are focused to the following healthcare segments:

Digital Technology

Neurology

Pain

Cardio-vascular

Oncology

Dermatology

Renal &

Gynecology

OUR COMPANY

OUR INSPIRATION

We are committed to bring together the best of science and technology and aim to build breakthrough knowledge.

Our work is inspired by creating complementing solutions for drug innovation & nutrition. We transfer disruptive ideas into tools that support operational evolution and improve success rates.

OUR MISSION
  • Extend the forefront of science

  • Lead innovation beyond existing solutions

  • Employ best technologies​

  • Generate sustainable values

  • Improve healthcare

OUR VISION

Be good and do good

 

Leadership

IMG_2303.jpg

Dr. Stebler is the Chief Executive Officer of CureOmics. He has 15 years of experience in the biotechnology and pharmaceutical industry and worked for Kuros Biosurgery, Xeltis, Novartis, and API suppliers. Dr. Stebler is a scientist and economist who has dedicated his career during past years to improve the lives of people with serious diseases. His experience spans clinical and non-clinical research whereas he was also leading teams in business development, GMP manufacturing, regulatory affairs, quality assurance and intellectual property.

 

Dr. Stebler holds a PhD in Molecular Biology from the Max Planck Institute & University of Göttingen, a MBA from the IE Business School Madrid, a B.Sc. in Chemistry and is certified in Plant-Based Nutrition from the T. Colin Campbell Center for Nutrition Studies. His executive educations in Decision Analysis from Stanford University and Digital Business Strategy from the Massachusetts Institute of Technology will additionally serve CureOmics to achieve the strategic and operational objectives.

DR. JÜRG STEBLER, MBA

CEO

 

GET IN TOUCH

Office Switzerland

General-Guisan-Strasse 6

6300 Zug

Switzerland

 

Office Asia​

20th Floor, Central Tower

28 Queen's Road, Central

Hong Kong
 

info(at)cureomics.com

www.cureomics.com